LON:RWS - RWS Holdings plc (RWS.L) Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: GBX 613.33
  • Forecasted Upside: 8.72 %
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
GBX 564.16
▲ +5.16 (0.92%)
1 month | 3 months | 12 months
Get New RWS Holdings plc (RWS.L) Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RWS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RWS

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
GBX 613.33
▲ +8.72% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for RWS Holdings plc (RWS.L) in the last 3 months. The average price target is GBX 613.33, with a high forecast of GBX 700 and a low forecast of GBX 530. The average price target represents a 8.72% upside from the last price of GBX 564.16.
Buy
The current consensus among 3 contributing investment analysts is to buy stock in RWS Holdings plc (RWS.L). This rating has held steady since January 2019, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/13/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/11/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/10/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/9/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/7/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/5/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/4/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/4/2020

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetDetails
9/1/2020BarclaysReiterated RatingOverweightGBX 610
i
7/3/2020Berenberg BankReiterated RatingBuy
i
6/10/2020BarclaysLower Price TargetOverweightGBX 630 ➝ GBX 610
i
6/9/2020Berenberg BankBoost Price TargetBuyGBX 650 ➝ GBX 700
i
4/24/2020HSBCLower Price TargetHoldGBX 600 ➝ GBX 530
i
1/13/2020HSBCReiterated RatingHold
i
12/18/2019BarclaysBoost Price TargetOverweightGBX 615 ➝ GBX 630
i
12/10/2019Berenberg BankBoost Price TargetBuyGBX 670 ➝ GBX 740
i
10/16/2019Deutsche Bank AktiengesellschaftReiterated RatingOverweightGBX 615
i
10/16/2019BarclaysBoost Price TargetOverweightGBX 610 ➝ GBX 615
i
10/4/2019Berenberg BankReiterated RatingBuy
i
6/12/2019BarclaysBoost Price TargetOverweightGBX 560 ➝ GBX 610
i
6/11/2019Berenberg BankBoost Price TargetBuyGBX 615 ➝ GBX 670
i
6/6/2019Numis SecuritiesDowngradeAddGBX 450 ➝ GBX 600
i
4/18/2019Berenberg BankBoost Price TargetBuyGBX 530 ➝ GBX 615
i
1/18/2019BarclaysInitiated CoverageOverweightGBX 560
i
10/10/2018Numis SecuritiesDowngradeAddGBX 510
i
6/22/2018Berenberg BankReiterated RatingBuyGBX 530
i
6/7/2018Shore CapitalReiterated RatingHold
i
6/7/2018Numis SecuritiesUpgradeBuyGBX 490 ➝ GBX 450
i
4/24/2018Numis SecuritiesReiterated RatingAddGBX 490
i
4/24/2018Shore CapitalReiterated RatingHoldGBX 459
i
3/28/2018Berenberg BankReiterated RatingBuyGBX 530
i
2/13/2018Numis SecuritiesReiterated RatingAddGBX 490
i
12/7/2017Berenberg BankReiterated RatingBuyGBX 530
i
12/6/2017Numis SecuritiesUpgradeAddGBX 490
i
12/6/2017Shore CapitalReiterated RatingHold
i
11/29/2017Berenberg BankInitiated CoverageBuyGBX 530
i
10/19/2017Numis SecuritiesBoost Price TargetHoldGBX 430 ➝ GBX 490
i
10/18/2017Shore CapitalReiterated RatingHold
i
10/8/2017Numis SecuritiesBoost Price TargetHoldGBX 375 ➝ GBX 430
i
10/2/2017Numis SecuritiesReiterated RatingHoldGBX 375
i
10/2/2017Shore CapitalReiterated RatingHold
i
8/10/2017Shore CapitalReiterated RatingHold
i
8/3/2017Shore CapitalDowngradeHold
i
7/6/2017CitigroupInitiated CoverageNeutralGBX 395
i
6/20/2017Shore CapitalReiterated RatingBuy
i
4/12/2017Numis SecuritiesReiterated RatingAddGBX 375
i
4/12/2017Shore CapitalReiterated RatingBuy
i
2/14/2017Numis SecuritiesReiterated RatingAddGBX 375
i
2/14/2017Shore CapitalReiterated RatingBuy
i
12/6/2016Numis SecuritiesReiterated RatingAddGBX 335
i
10/11/2016Numis SecuritiesBoost Price TargetAddGBX 255 ➝ GBX 295
i
6/7/2016Numis SecuritiesReiterated RatingAddGBX 255
i
4/12/2016Numis SecuritiesDowngradeAddGBX 230 ➝ GBX 255
i
12/8/2015Numis SecuritiesBoost Price TargetHoldGBX 185 ➝ GBX 210
i
(Data available from 12/4/2015 forward)
RWS Holdings plc (RWS.L) logo
RWS Holdings plc engages in the translation, intellectual property (IP) support, life sciences language, and localization businesses. The company operates through IP Services, Life Sciences, and Moravia segments. The IP Services segment provides patent translation and filing solutions, as well as IP search services. The Life Sciences segment offers a full suite of language services, including language solutions for clinical trial management; linguistic validation of clinical outcomes assessments; and regulatory affairs expertise, medical device documentation, and marketing and communications services, as well as e-learning and training programs for the life sciences industry. The Moravia segment provide localized products and content to consumers. It serves technology, pharmaceutical, medical, chemical, automotive, and telecommunication sectors. The company primarily operates in the United Kingdom, the United States, Continental Europe, and internationally. RWS Holdings plc was founded in 1958 and is headquartered in Chalfont St Peter, the United Kingdom.
Read More

Today's Range

Now: GBX 564.16
556
570

50 Day Range

MA: GBX 575.12
548.73
622.23

52 Week Range

Now: GBX 564.16
399.71
767

Volume

238,684 shs

Average Volume

430,672 shs

Market Capitalization

£2.19 billion

P/E Ratio

35.48

Dividend Yield

1.53%

Beta

N/A